The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

D. Karpova, K. Dauber, G. Spohn, D. Chudziak, E. Wiercinska, M. Schulz, A. R. Pettit, J. P. Levesque, B. Romagnoli, K. Patel, E. Chevalier, K. Dembowsky, H. Bonig

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor'. Together they form a unique fingerprint.

Medicine & Life Sciences